Condition: Nasopharyngeal Carcinoma by AJCC V8 Stage · Sponsor: Fujian Cancer Hospital
This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. The aim of this study is to evaluate the efficacy and safety of modified IMRT, of which CTV delineation was only based on geometric expansion from GTV.
This description comes directly from the study's public registry record.
Shaojun Lin, DR · 13860603879 · linshaojun@yeah.net
Qiaojuan Guo, DR · 15080013157 · guoqiaojuan163@.com
Always discuss trial participation with your own doctor first.
| Fujian Cancer hospital | Fuzhou, Fujian, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06095154